China's mRNA Boost - The Wire China

China may be set to take a major step towards catching up with Western nations in the global vaccine race. Whether that will lead Beijing to change its stringent approach to the pandemic is still open to doubt. In November, Suzhou Abogen Biosciences and two partners — Yunnan-based Walvax Biotechnology and the Chinese Academy of Military Medical Sciences — received approval from the Chinese authorities to test its new ARCoVax vaccine in a booster trial. If it proves effective, ARCoVax woul

Subscribe or login to read the rest.

Subscribers get full access to:

Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.

We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.

Broken Engagement

An ebook collection of interviews with the American policy makers who have shaped the U.S.'s relationship with China under six presidential administrations, carried out by former Wall Street Journal senior editor Bob Davis.

Interviews include Nancy Pelosi, Robert Lighthizer, Charlene Barshefsky, Robert Gates, Ash Carter, Robert Rubin and more.

The Wire China

China’s mRNA Boost

With a mRNA vaccine finally in trials, will China change its Covid approach?

All the President’s Generals

China Tariffs: Where Are We Now?
By Noah Berman

Paul G. Clifford on How China Made it Easier to Move Things Around
By Rachel Cheung

PURCHASE HERE

Broken Engagement

The Wire China Archives

China Tariffs: Where Are We Now? By Noah Berman

Paul G. Clifford on How China Made it Easier to Move Things Around By Rachel Cheung

Broken Engagement

The Wire China Archives

China Tariffs: Where Are We Now?
By Noah Berman

Paul G. Clifford on How China Made it Easier to Move Things Around
By Rachel Cheung